4//SEC Filing
Edge Therapeutics, Inc. 4
Accession 0001127602-17-011377
$PDSBCIK 0001472091operating
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 1:47 PM ET
Size
7.4 KB
Accession
0001127602-17-011377
Insider Transaction Report
Form 4
Einhorn Andrew J.
Chief Financial Officer
Transactions
- Exercise of In-Money
Common Stock
2017-03-01$2.39/sh+1,567$3,745→ 43,223 total - Exercise of In-Money
Warrants (right To Purchase)
2017-03-01−1,567→ 0 totalExercise: $2.39From: 2012-09-09Exp: 2017-09-09→ Common Stock (1,567 underlying)
Holdings
- 83,592(indirect: By LLC)
Common Stock
Footnotes (1)
- [F1]The Reporting Person is the sole managing member of Harpua, LLC and may be deemed to beneficially own these shares. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
Documents
Issuer
Edge Therapeutics, Inc.
CIK 0001472091
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001472091
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 1:47 PM ET
- Size
- 7.4 KB